enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
0.7415
-0.0455 (-5.78%)
At close: Oct 17, 2025, 4:00 PM EDT
0.7748
+0.0333 (4.49%)
After-hours: Oct 17, 2025, 6:06 PM EDT
enVVeno Medical Market Cap
enVVeno Medical has a market cap or net worth of $14.27 million as of October 17, 2025. Its market cap has decreased by -74.57% in one year.
Market Cap
14.27M
Enterprise Value
-19.99M
1-Year Change
-74.57%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since May 31, 2018, enVVeno Medical's market cap has decreased from $40.00M to $14.27M, a decrease of -64.32%. That is a compound annual growth rate of -13.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 14.27M | -73.05% |
| Dec 31, 2024 | 52.96M | -22.63% |
| Dec 29, 2023 | 68.45M | 41.69% |
| Dec 30, 2022 | 48.31M | -22.58% |
| Dec 31, 2021 | 62.40M | 222.87% |
| Dec 31, 2020 | 19.33M | 96.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |